SCHEMBL6980671

SCHEMBL6980671

CNc1cc(N2CCN(C(=O)C3CCN(S(=O)(=O)c4ccc(C(F)(F)F)cc4)CC3)CC2)ncn1

nearest known ligand 0.51

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CCR6 P51684 3/20 0.51
LSS P48449 2/20 0.49
MAPT P10636 2/20 0.48
KDM4E B2RXH2 2/20 0.48
ALDH1A1 P00352 1/20 0.48
NPC1 O15118 1/20 0.48
RAB9A P51151 1/20 0.48
EPHX2 P34913 1/20 0.47
CNR1 P21554 2/20 0.47
MAPK1 P28482 2/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
GAA P10253 1/20 0.46
USP2 O75604 1/20 0.46
LMNA P02545 1/20 0.46
TSHR P16473 1/20 0.46
HSD17B10 Q99714 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
POLB P06746 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6981045 0.96 LSS (0.54) CCR6LSSMAPTKDM4EALDH1A1
SCHEMBL6978885 0.88 ALDH1A1 (0.54) CCR6MAPTKDM4EALDH1A1EPHX2
SCHEMBL6978502 0.86 LSS (0.52) CCR6LSSMAPTKDM4ENPC1
SCHEMBL7085163 0.85 LSS (0.69) LSSALDH1A1NPC1RAB9ACNR1
SCHEMBL6970581 0.83 LSS (0.56) LSSMAPTKDM4EALDH1A1CNR1
SCHEMBL6977047 0.76 LSS (0.51) LSSMAPTKDM4EALDH1A1SMN1; SMN2
SCHEMBL26429307 0.75 ALDH1A1 (0.57) MAPTKDM4EALDH1A1EPHX2MAPK1
SCHEMBL6975446 0.74 KDM4E (0.53) MAPTKDM4EALDH1A1CNR1GAA
SCHEMBL7654951 0.72 LSS (0.72) LSSMAPTALDH1A1NPC1RAB9A
SCHEMBL6980850 0.72 LSS (0.61) LSSALDH1A1NPC1RAB9ACNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0925286-B1 SUBSTITUTED PYRIMIDINE DERIVATIVES AND THEIR PHARMACEUTICAL USE ASTRAZENECA AB (SE) 2003-01-02 EP disclosed
US-6093718-A AN OXIDO-SQUALENE CYCLASE INHIBITOR, ANTICHOLESTEROL AGENT FOR INHIBITING CHOLESTEROL BIOSYNTHESIS AND LOWERING CHOLESTEROL LEVELS IN BLOOD PLASMA; TREATING HYPERCHOLESTEROLEMIA AND ATHEROSCLEROSIS ZENECA LIMITED (GB) 2000-07-25 US disclosed